Inhibitors of the vascular calcification process, such as fetuin A, pyrophosphate, osteoprotegerin and Gla matrix protein (MGP), have a distinct activity in patients with CKD, as illustrated in Figure 3 [77]. The gene discussed is MGP; the disease is chronic kidney disease.